Document Detail


Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects.
MedLine Citation:
PMID:  18062896     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The renin-angiotensin system (RAS) is a hormonal system that controls body fluid volume, blood pressure, and cardiovascular function in both health and disease. Various tissues, including the heart and kidneys, possess individual locally regulated RASs. In each RAS, the substrate protein angiotensinogen is cleaved by the peptidases renin and angiotensin-converting enzyme to form the biologically active product angiotensin II, which acts as an intracrine cardiac and renal hormone. The components of each RAS, including aldosterone (ALDO), may be produced locally and/or may be delivered by or sequestered from the circulation. Overactivity of the cardiac RAS has been associated with cardiac diseases, including cardiac hypertrophy due to volume and/or pressure overload, heart failure, coronary artery disease with myocardial infarction, and hypertension. Overactivity of the renal RAS has been associated with various kidney diseases, including nephropathies and renal artery stenosis. The principal effects of an overactive RAS include the generation of reactive oxygen species, which leads to "oxidative stress," activation of the nuclear transcription factor kappaB, and stimulation of pathways and genes that promote vasoconstriction, endothelial dysfunction, cell hypertrophy, fibroblast proliferation, inflammation, excess extracellular matrix deposition, atherosclerosis, and thrombosis. It has been suggested that oxidative stress is the central mechanism underlying the pathogenesis of RAS-related and ALDO-related chronic cardiovascular and renal tissue injury and of cardiac arrhythmias and conduction disturbances.
Authors:
Veena Raizada; Betty Skipper; Wentao Luo; Jeffrey Griffith
Related Documents :
849636 - Natriuretic response to saline infusion in normotensive and hypertensive man. the role ...
2066966 - Renin inhibitors containing esters at the p2-position. oral activity in a derivative of...
7084486 - The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hyperte...
2666616 - Immunological approach to blockade of the renin-substrate reaction.
10072736 - Protection against hypoxia-reoxygenation in the absence of poly (adp-ribose) synthetase...
19963766 - Time-frequency representation of cardiovascular signals during handgrip exercise.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of investigative medicine : the official publication of the American Federation for Clinical Research     Volume:  55     ISSN:  1081-5589     ISO Abbreviation:  J. Investig. Med.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-12-07     Completed Date:  2008-04-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9501229     Medline TA:  J Investig Med     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  341-59     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of New Mexico, Albuquerque, NM 87131-0001, USA. vraizada@salud.unm.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Diseases / etiology*
Humans
Kidney Diseases / etiology*
Renin-Angiotensin System / physiology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biomarkers of acute kidney injury: early diagnosis, pathogenesis, and recovery.
Next Document:  Acetylcholinesterase activity in veterans of the first Gulf War.